Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Views & Analysis Patient-centric trials – dream or reality? Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?
Views & Analysis Collaboration the key to success in respiratory research Lung research needs support as fifth of UK diagnosed with respiratory condition.
Views & Analysis Access and elimination: the future of DAAs in hepatitis C How direct-acting antivirals are transforming treatment of hepatitis C.
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
